195 related articles for article (PubMed ID: 18539157)
1. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats.
Wenzel P; Schulz E; Oelze M; Müller J; Schuhmacher S; Alhamdani MS; Debrezion J; Hortmann M; Reifenberg K; Fleming I; Münzel T; Daiber A
Free Radic Biol Med; 2008 Sep; 45(5):619-26. PubMed ID: 18539157
[TBL] [Abstract][Full Text] [Related]
2. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.
Knorr M; Hausding M; Kröller-Schuhmacher S; Steven S; Oelze M; Heeren T; Scholz A; Gori T; Wenzel P; Schulz E; Daiber A; Münzel T
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2223-31. PubMed ID: 21757654
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
[TBL] [Abstract][Full Text] [Related]
4. AT1 receptor blocker potentiates shear-stress induced nitric oxide production via modulation of eNOS phosphorylation of residues Thr(495) and Ser(1177.).
Barauna VG; Mantuan PR; Magalhães FC; Campos LC; Krieger JE
Biochem Biophys Res Commun; 2013 Nov; 441(4):713-9. PubMed ID: 24211212
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
Lakshmanan AP; Watanabe K; Thandavarayan RA; Sari FR; Harima M; Giridharan VV; Soetikno V; Kodama M; Aizawa Y
Free Radic Res; 2011 May; 45(5):575-84. PubMed ID: 21381899
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats.
Hasegawa G; Fukui M; Hosoda H; Asano M; Harusato I; Tanaka M; Shiraishi E; Senmaru T; Sakabe K; Yamasaki M; Kitawaki J; Fujinami A; Ohta M; Obayashi H; Nakamura N
Eur J Pharmacol; 2009 Mar; 605(1-3):164-9. PubMed ID: 19171132
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase.
Yuen CY; Wong WT; Tian XY; Wong SL; Lau CW; Yu J; Tomlinson B; Yao X; Huang Y
Cardiovasc Res; 2011 Apr; 90(1):122-9. PubMed ID: 21156825
[TBL] [Abstract][Full Text] [Related]
8. Effect of telmisartan on the expression of cardiac adiponectin and its receptor 1 in type 2 diabetic rats.
Guo Z; Zheng C; Qin Z; Wei P
J Pharm Pharmacol; 2011 Jan; 63(1):87-94. PubMed ID: 21155820
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan protects against vascular dysfunction with peroxisome proliferator-activated receptor-γ activation in hypertensive 5/6 nephrectomized rats.
Toba H; Wang J; Ohigashi M; Kobara M; Nakata T
Pharmacology; 2013; 92(5-6):265-75. PubMed ID: 24281041
[TBL] [Abstract][Full Text] [Related]
10. Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats.
Chaudagar KK; Mehta AA
Clin Exp Hypertens; 2014; 36(8):557-66. PubMed ID: 24490705
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus.
Schäfer A; Flierl U; Vogt C; Menninger S; Tas P; Ertl G; Bauersachs J
Pharmacol Res; 2007 Sep; 56(3):217-23. PubMed ID: 17669665
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
13. Administration of telmisartan reduced systolic blood pressure and oxidative stress probably through the activation of PI3K/Akt/eNOS pathway and NO release in spontaneously hypertensive rats.
Xu L; Liu Y
Physiol Res; 2013; 62(4):351-9. PubMed ID: 23590610
[TBL] [Abstract][Full Text] [Related]
14. Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS.
Ding H; Hashem M; Triggle C
Eur J Pharmacol; 2007 Apr; 561(1-3):121-8. PubMed ID: 17292348
[TBL] [Abstract][Full Text] [Related]
15. Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats.
Serizawa K; Yogo K; Aizawa K; Tashiro Y; Ishizuka N
Cardiovasc Diabetol; 2011 Nov; 10():105. PubMed ID: 22107602
[TBL] [Abstract][Full Text] [Related]
16. Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage.
Jung KH; Chu K; Lee ST; Kim SJ; Song EC; Kim EH; Park DK; Sinn DI; Kim JM; Kim M; Roh JK
J Pharmacol Exp Ther; 2007 Sep; 322(3):1051-8. PubMed ID: 17538008
[TBL] [Abstract][Full Text] [Related]
17. DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy.
Alter ML; Ott IM; von Websky K; Tsuprykov O; Sharkovska Y; Krause-Relle K; Raila J; Henze A; Klein T; Hocher B
Kidney Blood Press Res; 2012; 36(1):119-30. PubMed ID: 23171828
[TBL] [Abstract][Full Text] [Related]
18. Effect of Telmisartan or Insulin on the Expression of Adiponectin and its Receptors in the Testis of Streptozotocin-Induced Diabetic Rats.
Guo Z; Yan X; Wang L; Wu J; Jing X; Liu J
Horm Metab Res; 2016 Jun; 48(6):404-12. PubMed ID: 26849825
[TBL] [Abstract][Full Text] [Related]
19. Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose.
Taye A; Saad AH; Kumar AH; Morawietz H
Eur J Pharmacol; 2010 Feb; 627(1-3):42-8. PubMed ID: 19878672
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
